These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21386631)

  • 1. Adjuvant therapy of pancreatic cancer: beyond gemcitabine. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
    Saif MW
    JOP; 2011 Mar; 12(2):106-9. PubMed ID: 21386631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant treatment of pancreatic cancer in 2009: where are we? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
    Saif MW
    JOP; 2009 Jul; 10(4):373-7. PubMed ID: 19581737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversies in the adjuvant treatment of pancreatic adenocarcinoma.
    Saif MW
    JOP; 2007 Sep; 8(5):545-52. PubMed ID: 17873458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
    Chang BW; Saif MW
    JOP; 2011 Mar; 12(2):101-5. PubMed ID: 21386630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates in adjuvant therapy in pancreatic cancer: gemcitabine and beyond. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
    Richter J; Saif MW
    JOP; 2010 Mar; 11(2):144-7. PubMed ID: 20208323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant and adjuvant strategies for pancreatic cancer.
    Ghaneh P; Smith R; Tudor-Smith C; Raraty M; Neoptolemos JP
    Eur J Surg Oncol; 2008 Mar; 34(3):297-305. PubMed ID: 17936564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-line treatment for advanced pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
    Oberstein PE; Saif MW
    JOP; 2011 Mar; 12(2):96-100. PubMed ID: 21386629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment for refractory pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
    Makrilia N; Syrigos KN; Saif MW
    JOP; 2011 Mar; 12(2):110-3. PubMed ID: 21386632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancements in the management of pancreatic cancer.
    Li J; Saif MW
    JOP; 2009 Mar; 10(2):109-17. PubMed ID: 19287102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.
    Neoptolemos JP; Stocken DD; Bassi C; Ghaneh P; Cunningham D; Goldstein D; Padbury R; Moore MJ; Gallinger S; Mariette C; Wente MN; Izbicki JR; Friess H; Lerch MM; Dervenis C; Oláh A; Butturini G; Doi R; Lind PA; Smith D; Valle JW; Palmer DH; Buckels JA; Thompson J; McKay CJ; Rawcliffe CL; Büchler MW;
    JAMA; 2010 Sep; 304(10):1073-81. PubMed ID: 20823433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapy in pancreatic cancer: a critical appraisal.
    Oettle H; Neuhaus P
    Drugs; 2007; 67(16):2293-310. PubMed ID: 17983252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is S-1 a potential game changer in adjuvant therapy of pancreatic cancer?
    Chaulagain CP; Rothschild J; Saif MW
    JOP; 2013 Jul; 14(4):329-33. PubMed ID: 23846920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant and neoadjuvant treatment in pancreatic cancer.
    Herreros-Villanueva M; Hijona E; Cosme A; Bujanda L
    World J Gastroenterol; 2012 Apr; 18(14):1565-72. PubMed ID: 22529684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study.
    Hardacre JM; Mulcahy M; Small W; Talamonti M; Obel J; Krishnamurthi S; Rocha-Lima CS; Safran H; Lenz HJ; Chiorean EG
    J Gastrointest Surg; 2013 Jan; 17(1):94-100; discussion p. 100-1. PubMed ID: 23229886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The recent past and future of adjuvant therapy for pancreatic cancer.
    Yeo CJ
    Ann Surg Oncol; 2003 Jun; 10(5):488-9. PubMed ID: 12794012
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant chemoradiation for pancreatic cancer: few good data, much debate.
    Twombly R
    J Natl Cancer Inst; 2008 Dec; 100(23):1670-1. PubMed ID: 19033566
    [No Abstract]   [Full Text] [Related]  

  • 17. Ampullary and periampullary tumors: translational efforts to meet a challenge in diagnosis and treatment. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
    Kang SP; Saif MW
    JOP; 2011 Mar; 12(2):123-5. PubMed ID: 21386636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant treatment of pancreatic cancer].
    Oettle H
    Zentralbl Chir; 2003 May; 128(5):411-8. PubMed ID: 12813641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant and additive therapy for cancer of the pancreas].
    Neoptolemos JP; Raraty MG; Ghaneh P; Hickey H; Stocken DD; Dunn JA; Friess H; Büchler MW
    Chirurg; 2003 Mar; 74(3):191-201. PubMed ID: 12647075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine-based combination chemotherapy followed by radiation with capecitabine as adjuvant therapy for resected pancreas cancer.
    Desai S; Ben-Josef E; Griffith KA; Simeone D; Greenson JK; Francis IR; Hampton J; Colletti L; Chang AE; Lawrence TS; Zalupski MM
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1450-5. PubMed ID: 19409732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.